Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Junichi KUREBAYASHI"'
Autor:
Toshiaki Akahane, Naoki Kanomata, Oi Harada, Tetsumasa Yamashita, Junichi Kurebayashi, Akihide Tanimoto, Takuya Moriya
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Next-generation sequencing (NGS) has shown that recurrent/metastatic breast cancer lesions may have additional genetic changes compared with the primary tumor. These additional changes may be related to tumor progression and/or dr
Externí odkaz:
https://doaj.org/article/4a94328c201145c397ad92c2dc7126b0
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Invasive micropapillary carcinoma (IMPC) of the breast is characterized by its unique morphology and frequent nodal metastasis. However, the mechanism for development of this unique subtype has not been clearly elucidated. The aim
Externí odkaz:
https://doaj.org/article/bfbf13c7f03f4ba9872b1a231e57f42d
Autor:
Naoki Kanomata, Shiro Matsuura, Tsunehisa Nomura, Junichi Kurebayashi, Taisuke Mori, Jo Kitawaki, Takuya Moriya
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183202 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0177439.].
Externí odkaz:
https://doaj.org/article/8f394ac689cc4846bc551eeedfbf532e
Autor:
Naoki Kanomata, Shiro Matsuura, Tsunehisa Nomura, Junichi Kurebayashi, Taisuke Mori, Jo Kitawaki, Takuya Moriya
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177439 (2017)
Aromatase inhibitors have been widely used for the endocrine treatment of estrogen-dependent breast cancer in postmenopausal patients. However, clinicopathological studies of aromatase have been limited due to unsatisfactory specificity and/or restri
Externí odkaz:
https://doaj.org/article/869cb7d2a4c64709858836cb7c1c667d
Autor:
Toshiro Shimo, Katsuhiro Tanaka, Ryohei Ogata, Wataru Saito, Yusuke Ohta, Yoshikazu Koike, Tetsumasa Yamashita, Yutaka Yamamoto, Junichi Kurebayashi
Publikováno v:
Case Reports in Endocrinology, Vol 2014 (2014)
The patient was a 44-year-old woman who exhibited a diffuse goiter during health screening. Her medical history did not include any significant medication-based treatment. An echographic examination detected a solid cystic tumor, which measured 21 ×
Externí odkaz:
https://doaj.org/article/e9c07e9509ec47e1a64c2a8827c65dac
Supplementary Table 1 from Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::217196e396a3f71a4a5b802e4a23c2fe
https://doi.org/10.1158/0008-5472.22368023.v1
https://doi.org/10.1158/0008-5472.22368023.v1
Fibroblast growth factor (FGF) signals play fundamental roles in development and tumorigenesis. Thyroid cancer is an example of a tumor with nonoverlapping genetic mutations that up-regulate mitogen-activated protein kinase (MAPK). Here, we show that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd22985ed683e8a83b1336b64e2a791
https://doi.org/10.1158/0008-5472.c.6495782
https://doi.org/10.1158/0008-5472.c.6495782
Autor:
Yutaka YAMAMOTO1 yamayou@med.kawasaki-m.ac.jp, Junichi KUREBAYASHI1, Hiroshi OKAMOTO2, Yuka MIKAMI3, Takuya MORIYA3, Yuna FUKUMA1, Tsuyoshi MIKAMI1, Shiori KAWANO1, Emi KISHINO1, Ryohei OGATA1, Wataru SAITO1, Yoshikazu KOIKE1, Mai SOHDA1, Tsunehisa NOMURA1, Katsuhiro TANAKA1
Publikováno v:
Kawasaki Medical Journal. 2021, Vol. 47, p69-75. 7p.
Autor:
Jun Yamamoto, Junichi Kurebayashi, Wataru Saito, Robert M. Hoffman, Tsunehisa Nomura, Takuya Murata, Takuya Moriya, Chihiro Hozumi
Publikováno v:
Anticancer Research. 41:6191-6197
Background Matrix-producing breast carcinoma (MPBC) is a very rare and usually aggressive triple-negative breast cancer. We successfully established a patient-derived orthotopic xenograft (PDOX) model from a patient with MPBC and used it to study tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc368b24990a403c8f11e94d23182ce
https://doi.org/10.21873/anticanres.15438
https://doi.org/10.21873/anticanres.15438
Autor:
Ryohei, Ogata, Yutaka, Yamamoto, Azusa, Jo, Yuna, Fukuma, Tsuyoshi, Mikami, Shiori, Kawano, Emi, Kishino, Wataru, Saito, Yoshikazu, Koike, Mai, Soda, Tsunehisa, Nomura, Katsuhiro, Tanaka, Junichi, Kurebayashi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(6)
Clinical studies have confirmed that nab-paclitaxel(nab-PTX)therapy is effective and safe in patients with metastatic breast cancer. Neoadjuvant chemotherapy(NAC) with nab-PTX has resulted in a pathological complete response (pCR) rate of 29% in all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfd4eb558e8eeab4405df1ef5786bde2
https://pubmed.ncbi.nlm.nih.gov/35799395
https://pubmed.ncbi.nlm.nih.gov/35799395